Growth impairment of small-cell cancer by targeting pro-vasopressin with MAG-1 antibody

作者: William G. North , Bernard Cole , Bonnie Akerman , Roy H. L. Pang

DOI: 10.3389/FONC.2014.00016

关键词:

摘要: AbstractPreviously we demonstrated that human small-cell lung cancer (SCLC) seems to universally express the vasopressin gene, and this leads presence of a cell-surface marker representing entire prohormone precursor. In study show can be targeted with MAG-1, mouse monoclonal antibody against C-terminal moiety on provasopressin. vitro targeting cell lines derived from primary recurrent disease demonstrates attachment surface followed by internalization. vivo 99Tc-labeled Fab fragments MAG-1 shows selective xenografts. treatment tumors classical line, NCI H345, either ~1.65 µCi (~1.65 mg)/kg bw 90 Yttrium-labeled or mg/kg native delivered every second day for 6 days produced similar reductions in growth rate ~50% (p

参考文章(37)
W. G. North, J. Ware, A. P. Chahinian, M. Perry, J. O’Donnell, L. H. Maurer, Clinical evaluation of the neurophysins as tumor markers in small cell lung cancer. Recent results in cancer research. ,vol. 99, pp. 187- 193 ,(1985) , 10.1007/978-3-642-82533-0_21
Christine L Hann, Charles M Rudin, Management of small-cell lung cancer: incremental changes but hope for the future. Oncology. ,vol. 22, pp. 1486- 1492 ,(2008)
William G. North, Kenneth A. Longo, Jinlin Du, Michael J. Fay, Expression of All Known Vasopressin Receptor Subtypes by Small Cell Tumors Implies a Multifaceted Role for this Neuropeptide Cancer Research. ,vol. 58, pp. 1866- 1871 ,(1998)
Tohru Mochzuki, Russell Tolley, Paul A. Bunn, Lajos Gera, Philip Jewett, John Stewart, Maureen Tagawa, Charlotte Alford, Noboru Yanaihara, Daniel Chan, Effects of Neuropeptide Analogues on Calcium Flux and Proliferation in Lung Cancer Cell Lines Cancer Research. ,vol. 54, pp. 3602- 3610 ,(1994)
John D. Minna, Adi F. Gazdar, Paul J. Marangos, Terry W. Moody, Mark H. Zweig, Gerold Bepler, Desmond N. Carney, John G. Guccion, Establishment and Identification of Small Cell Lung Cancer Cell Lines Having Classic and Variant Features Cancer Research. ,vol. 45, pp. 2913- 2923 ,(1985)
L H Maurer, J E Herndon, D R Hollis, J Aisner, R W Carey, A T Skarin, M C Perry, W L Eaton, L L Zacharski, S Hammond, M R Green, Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study. Journal of Clinical Oncology. ,vol. 15, pp. 3378- 3387 ,(1997) , 10.1200/JCO.1997.15.11.3378
B E Johnson, J Grayson, R W Makuch, R I Linnoila, M J Anderson, M H Cohen, E Glatstein, J D Minna, D C Ihde, Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Journal of Clinical Oncology. ,vol. 8, pp. 396- 401 ,(1990) , 10.1200/JCO.1990.8.3.396
AS Friedmann, KA Malott, VA Memoli, SI Pai, X-M Yu, WG North, Products of vasopressin gene expression in small-cell carcinoma of the lung British Journal of Cancer. ,vol. 69, pp. 260- 263 ,(1994) , 10.1038/BJC.1994.49
WILLIAM G. NORTH, L. HERBERT MAURER, HEINZ VALTIN, JOSEPH F. O'DONNELL, Human Neurophysins as Potential Tumor Markers for Small Cell Carcinoma of the Lung: Application of Specific Radioimmunoassays The Journal of Clinical Endocrinology and Metabolism. ,vol. 51, pp. 892- 896 ,(1980) , 10.1210/JCEM-51-4-892